Prime Medicine, Inc. - Common Stock, $0.00001 par value (PRME)

151 filings reported holding PRME - Prime Medicine, Inc. - Common Stock, $0.00001 par value as of Q4 2024.
Prime Medicine, Inc. - Common Stock, $0.00001 par value (PRME) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 64.3M shares of 179M outstanding shares and own 35.98% of the company stock.
Largest 10 shareholders include Alphabet Inc. (15.1M shares), ARK Investment Management LLC (5.15M shares), BlackRock, Inc. (4.52M shares), T. Rowe Price Investment Management, Inc. (3.98M shares), FMR LLC (3.8M shares), VANGUARD GROUP INC (3.66M shares), Sumitomo Mitsui Trust Group, Inc. (3.09M shares), Nikko Asset Management Americas, Inc. (3.09M shares), Redmile Group, LLC (2.07M shares), and MILLENNIUM MANAGEMENT LLC (1.87M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.